Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04373369 · TERMINATED
Trial details
- NCT number
- NCT04373369
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-08-18
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.